VERIMATRIX : Q2 2023 Revenue and H1 2023 Results
Regulatory News:
VERIMATRIX (Euronext Paris: VMX) has released its second-quarter revenue for 2023 and its financial results for H1-2023 to 30 June 2023.
"VERIMATRIX turned in a satisfactory first-half, with revenue growth driven by strong growth in revenue from subscriptions. These results reflect the quality of the ongoing transformation of VERIMATRIX to an economic model driven mainly by recurring revenues. A positioning underpinned by our offering of smart cybersecurity and content protection solutions tailored to the needs of our customers. Thanks to this favourable environment and the support of the sales teams for our strategic plan, we are raising our growth target for subscription revenue to 60% for 2023 versus 40% previously," says Amedeo D'Angelo, Executive Chairman of VERIMATRIX.
Amedeo d’Angelo, Executive Chairman and Jean-François Labadie, Chief Financial Officer will hold an audio webcast today at 6:00pm to discuss the Company’s half-year results and outlook.
To join the webcast, click on the following link:
Webcast - Résultats Verimatrix CA T2 - S1
To join the webcast, audio only, call the following number:
France: +33 (0) 4 88 80 09 30
Password: 405 098 907#
(in US$ million) |
|
Q2 23 |
Q2 22 |
Var. |
|
H1 23 |
H1 22 |
Var. |
Recurring turnover |
|
7,5 |
6,1 |
22 % |
|
15,0 |
12,3 |
22 % |
of which subscriptions |
|
3,3 |
1,6 |
108 % |
|
6,5 |
3,2 |
107 % |
of which maintenance |
|
4,2 |
4,5 |
-8 % |
|
8,5 |
9,1 |
-8 % |
Non-recurring turnover |
|
9,1 |
10,0 |
-9 % |
|
15,6 |
16,6 |
-6 % |
Total turnover |
|
16,6 |
16,2 |
3 % |
|
30,6 |
28,9 |
6 % |
|
|
|
|
|
|
|
|
|
ARR1 |
|
29,8 |
26,1 |
14% |
|
29,8 |
26,1 |
14% |
of which subscriptions |
|
13,4 |
8,0 |
67% |
|
13,4 |
8,0 |
67% |
of which maintenance |
|
16,4 |
18,1 |
-9% |
|
16,4 |
18,1 |
-9% |
Q2 2023 revenue
VERIMATRIX reported total revenue of $16.6 million in Q2, up from $16.2 million in Q2 2022, an increase of 3%. This increase was mainly due to strong growth in recurring revenue from subscriptions.
Recurring revenue
Total recurring revenue in Q2 2023 came to $7.5 million, up 22% on Q2 2022, attributable to a sharp increase in subscriptions and an anticipated and controlled decrease in maintenance revenue.
Subscription sales rose by 108% in Q2 2023 to $3.3 million compared with $1.6 million in Q2 2022. On a trend basis, compared with the end of 2022, annualised recurring revenue (ARR) from subscriptions rose by 21% to $13.4 million, showing a steady sequential increase over the past three quarters.
Maintenance revenue fell by 8% to $4.2 million compared with $4.5 million in Q2 2022. This decline was expected and controlled by the Group. It can be attributed to the strategy in place to transform the business model into an approach involving the conversion of one-off licence sales into recurring revenue. ARR from maintenance has remained stable over the last three quarters, reaching $16.4 million in the second quarter.
Non-recurring revenue
Non-recurring revenue came to $9.1 million in Q2 2023, down 9% on Q2 2022. This decline, which is limited and does not hinder the group's growth, is mainly linked to the resilience of the perpetual license market. In fact, the Asia-Pacific region showed particularly strong momentum in the second quarter, with the sale of perpetual licences to one of VERIMATRIX’s long-standing telecom operators.
H1 2023 revenue
H1 2023 revenue came to $30.6 million, up 6% on H1 2022, driven by a balanced mix of recurring and non-recurring revenue. Recurring revenue rose by 22% to $15 million, thanks to a sharp increase in subscriptions (+107% to $6.5 million) in H1 2023. Non-recurring revenue fell by 6% to $15.6 million.
This increase in revenue in the first half of 2023 compares with a decrease of 19% in H1 2022 compared with H1 2021. The sales momentum seen across the group throughout the first half of the year is in line with management’s business objective to generate growth in revenue and ARR from subscriptions and growth in total recurring revenue.
Recurring revenue accounted for 49% of total revenue compared with 42.5% in the same period in 2022. The share of subscription revenue continues to grow in line with the announced strategic plan. Recurring revenue from subscriptions accounted for 43% of total recurring revenues versus 26% in the first half of 2022.
H1 2023 results
Adjusted operating profit
(in US$ million) |
|
H1 23 |
H1 22 |
Var. |
|
|
|
|
|
Revenue |
|
30,6 |
28,9 |
+6% |
Gross profit |
|
22,1 |
20,8 |
+6% |
As a % of revenue |
|
72,2% |
71,9% |
+0,3pt |
Research & development expenses |
|
(10,0) |
(9,8) |
+2% |
Selling & marketing expenses |
|
(8,5) |
(7,1) |
+20% |
General & administrative expenses |
|
(6,1) |
(6,2) |
-2% |
Other gains / (losses), net |
|
0,2 |
0,4 |
-49% |
Total operating expenses |
|
(24,3) |
(22,6) |
+8% |
Adjusted operating income |
|
(2,2) |
(1,8) |
-21% |
As a % of revenue |
|
-7,5% |
-6,4% |
+1,1pt |
EBITDA |
|
0,4 |
0,2 |
+61% |
As a % of revenue |
|
1,2% |
0,8% |
+0,4pt |
In the first half of 2023, VERIMATRIX reported a gross profit of $22.1 million compared with $20.8 million in the first half of 2022, representing a gross profit of 72.2% versus 71.9%. This improvement in the gross profit is attributable to a volume effect from the increase in revenue combined with good cost control.
Adjusted operating expenses were held in check at $24.3 million, compared with $22.6 million, with a strong focus on investment in sales and marketing. After investing heavily in research and development to build its product offers, at the beginning of 2023 VERIMATRIX focused investment on sales and marketing to speed up its transformation. During the period, sales and marketing expenditure increased by 20% to $8.5 million, linked to specialised sales teams for new SaaS products and higher investment in marketing campaigns to boost VERIMATRIX’s visibility.
Overall, in the first half of the year, EBITDA increased to $0.4 million compared with $0.2 million in H1 2022.
There was an adjusted operating loss of $2.2 million (versus a loss of $1.8 million in H1 2022) due to an increase in depreciation expenses of $0.5 million related to the development of past R&D projects.
Reconciliation of adjusted operating income with operating income and net income in IFRS
(in US$ million) |
|
H1 23 |
H1 22 |
|
|
|
|
Adjusted operating income |
|
(2,2) |
(1,8) |
Amortization and depreciation of assets acquired through business combinations |
|
(1,5) |
(2,6) |
Acquisition-related expenses |
|
- |
(0,1) |
Non-recurring costs related to restructurations |
|
(0,6) |
(0,8) |
Share-based payments |
|
(0,3) |
(0,1) |
Operating income / (loss) |
|
(4,7) |
(5,4) |
Financial income / (loss), net |
|
(1,6) |
(1,6) |
Income tax expenses |
|
(1,0) |
(0,2) |
Net income / (loss) from continuing operations |
|
(7,3) |
(7,3) |
Depreciation and amortisation of assets acquired through business combinations decreased of $1.1 millio to $1.5 million, compared with $2.6 million in H1 2022. The depreciation period for part of Inside Secure’s acquisition of VERIMATRIX in 2019 is now complete.
During the period, restructuring costs amounted to $0.6 million versus $0.8 million the previous year.
VERIMATRIX recorded an operating loss of $4.7 million in the first half of 2023, compared with an operating loss of $5.4 million in the first half of 2022. Overall, after taking into account financial income and tax expense, the net loss from continuing operations remained level at $7.3 million.
Financial position and cash flows
(in US$ million) |
|
H1 23 |
H1 22 |
|
|
|
|
Income / (loss) from continuing operations |
|
(7,3) |
(7,3) |
Non-cash items from continuing operations |
|
7,4 |
7,0 |
Changes in working capital from continuing operations |
|
2,6 |
(2,2) |
Cash generated by / (used in) operating activities |
|
2,7 |
(2,6) |
Taxes paid |
|
(1,0) |
(0,7) |
Interests paid |
|
(1,5) |
(2,1) |
Net cash generated by / (used in) operating activities |
|
0,2 |
(5,4) |
Cash flows from / (used in) investing activities, net |
|
(1,7) |
(2,0) |
Cash flows from / (used in) financing activities, net |
|
(2,8) |
(18,2) |
Net increase / (decrease) in cash and cash equivalents |
|
(4,2) |
(25,7) |
Cash and cash equivalents at beginning of period |
|
30,0 |
45,3 |
Foreign exchange impact |
|
(0,1) |
(0,1) |
Cash and cash equivalents at end of period |
|
25,7 |
19,5 |
VERIMATRIX highlights the strong level of cash flow generated by operating activities, which amounted to $2.7 million in the first half of 2023 compared with -$2.6 million in the first half of 2022. This increase can be used to finance taxes and the debt burden.
Net cash from operating activities amounted to $0.2 million in the first half of 2023, compared with -$5.4 million the previous year. This improvement was mainly due to optimisation of the working capital and to control of operating margin of VERIMATRIX.
The cash used in investment activities, mainly R&D for product development, came to $1.7 million compared with $2.0 million the previous year. The cash used in financing activities amounted to $2.8 million compared with $18.2 million in H1 2022, which included the repayment of a $17.4 million convertible bond.
Net debt excluding lease commitments under IFRS 16 amounted to $6.2 million as at 30 June 2023 versus $8.9 million a year earlier and $3.7 million as at 31 December 2022. A portion of the private debt contracted with Apera was repaid in the amount of $2 million. The next debt repayment due date is scheduled for the beginning of fiscal year 2026.
In total, as at 30 June 2023, VERIMATRIX had a solid cash position of $25.7 million, compared with $19.5 million at the end of June 2022, thanks to moderate consumption of financial resources over the period, enabling it to finance the group's ongoing transformation.
Upward revision of full-year growth targets
On the back of these results, good sales of perpetual licenses in Q2 2023 and good momentum in embedded recurring revenues, VERIMATRIX has revised up its outlook for 2023. It now forecasts growth in recurring revenue from subscriptions of 60% in 2023 (versus 40% previously announced). It is maintaining its target for ARR from subscriptions of 40%.
Finally, given the momentum at play, VERIMATRIX's total recurring revenue, from both subscriptions and maintenance, is expected to show double-digit growth over the full year.
Financial calendar
Q3 revenue: 19 October 2023 (after market close)
About VERIMATRIX
VERIMATRIX (Euronext Paris: VMX) helps make today's connected world safer by offering user-centred security solutions. VERIMATRIX protects digital content, applications and devices with intuitive, people-centred and frictionless security. Leading brands turn to VERIMATRIX to protect their content, from premium films and live-streaming sports to sensitive financial and medical data and mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver quality content and services to millions of consumers around the world. VERIMATRIX helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. For more information, visit www.verimatrix.com.
Supplementary non-IFRS financial information
In this press release, VERIMATRIX uses financial aggregates and performance indicators which are not accounting metrics strictly defined by IFRS standards. They are defined in Appendix 2 of this press release. They must be considered supplemental information which is not a substitute for any operational and financial metric of a strictly accounting nature, as presented in the company’s consolidated financial statements, particularly in the profit and loss statement contained in Appendix 1 of this press release.
Forward-looking statements
This press release contains certain forward-looking statements concerning VERIMATRIX. Although VERIMATRIX believes its expectations to be based on reasonable assumptions, they do not constitute guarantees of future performance. Accordingly, the company’s actual results may differ materially from those anticipated in these forward-looking statements owing to a number of risks and uncertainties.
Appendix 1 - Supplementary non-IFRS financial information - Reconciliation of IFRS results with adjusted results
The performance indicators presented in this press release that are not strictly accounting metrics are defined below. These indicators are not aggregates defined under IFRS and do not constitute accounting metrics used to measure the company’s financial performance. They must be considered supplemental information which is not a substitute for any operational and financial metric of a strictly accounting nature, as presented in the company’s consolidated financial statements and accompanying notes. The company uses these indicators because it believes they are relevant measures of its current operating profitability and operating cash flow generation. Although generally used by companies in the same sector around the world, these indicators may not be strictly comparable to those of other companies as they may be defined or calculated differently even though similarly labelled.
Adjusted gross profit is defined as gross profit before (i) the amortisation of intangible assets related to business combinations, (ii) any potential goodwill impairment, (iii) share-based payment expenses and (iv) non-recurring costs associated with restructuring and acquisitions and disposals carried out by the company.
Adjusted operating profit is defined as operating profit before (i) the amortisation of intangible assets related to business combinations, (ii) any potential goodwill impairment, (iii) share-based payment expenses and (iv) non-recurring costs associated with restructuring and acquisitions and disposals carried out by the company.
EBITDA is defined as adjusted operating profit before depreciation, amortisation and impairment expenses not related to business combinations.
Annual recurring revenue (ARR) corresponds to the annualised value of all recurring revenue from contracts in place at the time of measurement. ARR includes all types of contracts that generate recurring revenue and for which revenue is currently recognised. ARR is a rolling number that accumulates over time whereas the total contract value (TCV) metric also used by the company is typically used to measure (new or incremental) orders made within a period. The company computes an ARR for SaaS and non-SaaS subscriptions and ARR combining subscriptions and maintenance.
Reconciliation of net debt
(in US$ million) |
|
30 juin
|
31 décembre
|
30 juin
|
|
|
|
||
Cash and cash equivalents |
25,7 |
30,0 |
19,5 |
|
Private loan note due 2026, at fair value |
(24,0) |
(26,0) |
(28,4) |
|
Convertible bonds due 2022 (OCEANE), at fair value |
(7,9) |
(7,8) |
- |
|
Net cash/(debt) |
|
(6,2) |
(3,7) |
(8,9) |
Financial lease commitments under IFRS16 |
(8,9) |
(9,6) |
(10,2) |
|
Net cash/(debt) including IFRS 16 |
|
(15,1) |
(13,4) |
(19,1) |
Appendix 2 – Consolidated financial statements (IFRS)
Consolidated income statement
(In US$ million) |
End of semester the 30th of June |
|
|
2023 |
2022 |
Revenue |
30,6 |
28,9 |
Cost of sales |
(9,2) |
(9,0) |
|
|
|
Gross profit |
21,4 |
19,9 |
|
||
Research and development expenses |
(10,5) |
(10,5) |
Selling and marketing expenses |
(9,0) |
(8,1) |
General and administrative expenses |
(6,2) |
(6,2) |
Other gains / (losses), net |
(0,3) |
(0,5) |
|
|
|
Operating profit (loss) |
(4,7) |
(5,4) |
|
||
Cost of financial debt, net |
(1,5) |
(2,8) |
Other financial income/(loss), net |
(0,1) |
1,2 |
|
|
|
Profit (loss) before income tax |
(6,3) |
(7,1) |
Income tax expenses |
(1,0) |
(0,2) |
|
|
|
Net income/(loss) consolidated |
(7,3) |
(7,3) |
Balance sheet
Assets |
||
(In US$ million) |
June 30,
|
December 31,
|
Goodwill |
115,2 |
115,2 |
Intangible assets |
14,7 |
16,5 |
Property and equipment |
6,4 |
7,0 |
Other receivables |
2,9 |
1,4 |
|
||
Non-current assets |
139,2 |
140,1 |
|
||
Inventories |
0,3 |
0,3 |
Trade receivables |
24,5 |
32,9 |
Other receivables |
6,2 |
6,1 |
Derivative financial instruments |
0,1 |
0,4 |
Cash and cash equivalents |
25,7 |
30,0 |
|
||
Current assets |
56,8 |
69,8 |
|
|
|
Total assets |
196,0 |
209,9 |
|
||
Equity and liabilities |
||
(In US$ million) |
June 30,
|
December 31, 2022 |
Ordinary shares |
41,5 |
41,5 |
Share premium |
94,7 |
94,7 |
Reserves and retained earnings |
(0,4) |
17,2 |
Income / (loss) for the period |
(7,3) |
(17,6) |
Equity attributable to equity holders of the Company |
128,6 |
135,9 |
|
||
Non-controlling interests |
|
- |
|
||
Total equity |
128,6 |
135,9 |
|
||
Borrowings |
39,2 |
39,8 |
Provisions |
1,6 |
1,7 |
Deferred tax liabilities |
0,9 |
0,9 |
Non-current liabilities |
41,7 |
42,5 |
|
||
Borrowings |
1,6 |
3,7 |
Convertible bonds |
|
- |
Trade payables |
3,4 |
5,4 |
Other liabilities |
8,0 |
10,3 |
Derivative and financial instruments |
0,0 |
0,0 |
Provisions |
0,5 |
0,2 |
Unearned revenues |
12,2 |
12,1 |
Current liabilities |
25,7 |
31,6 |
|
||
Total liabilities |
67,4 |
74,0 |
|
|
|
Total equity and liabilities |
196,0 |
209,9 |
Cash flow statement
(In US$ million) |
|
June 30,
|
June 30,
|
|
|
|
|
||
Income / (loss) for the period |
|
(7,3) |
(7,3) |
|
Non cash income statement items from continuing activities |
|
7,4 |
7,0 |
|
Changes in working capital from continuing operations |
|
2,6 |
(2,2) |
|
Cash generated by operating activities |
|
2,7 |
(2,6) |
|
|
|
|
||
Taxes paid |
|
(1,0) |
(0,7) |
|
Interests paid |
|
(1,6) |
(2,1) |
|
Net cash generated by / (used in) operating activities |
|
0,2 |
(5,4) |
|
|
|
|
||
Purchases of property and equipment |
|
(0,1) |
(0,1) |
|
Purchases of intangible assets |
|
(1,6) |
(1,9) |
|
Cash flows from investing activities |
|
(1,7) |
(2,0) |
|
|
|
|
|
|
Loan repayments |
|
(2,0) |
- |
|
Repayment of convertible bonds into shares |
|
- |
(17,5) |
|
Reimbursement of lease commitments under IFRS16 |
|
(0,8) |
(0,8) |
|
Cash flows from financing activities |
|
(2,8) |
(18,2) |
|
|
|
|
||
Effect of exchange rate fluctuation |
|
(0,1) |
(0,1) |
|
|
|
|
||
Net increase in cash and cash equivalents |
|
(4,3) |
(25,8) |
|
|
|
|
||
Cash and cash equivalents at beginning of the period |
|
30,0 |
45,3 |
|
Cash and cash equivalents at end of the period |
|
25,7 |
19,5 |
1 End of the period.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230724724890/en/
Contact information
Investor and media
I
nvestor Relations
Jean-François Labadie
Chief Financial Officer
+33 (0)4 42 905 905
finance@verimatrix.com
Investor Relations
Lucie Morlot
+33 (0)1 80 18 26 33
lucie.morlot@actifin.fr
Financial Press
Michael Scholze
+33 (0)1 56 88 11 14
michael.scholze@actifin.fr
Media Contact:
Matthew Zintel
+1 281 444 1590
matthew.zintel@zintelpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kioxia Receives IEEE Corporate Innovation Award9.5.2025 10:00:00 EEST | Press release
Kioxia Corporation, a world leader in memory solutions, today announced that it has received the IEEE Corporate Innovation Award from the Institute of Electrical & Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. This award recognizes Kioxia's outstanding contribution in the field of electrical and electronics engineering through its BiCS FLASH™ technology, a low-cost, high-capacity 3D flash memory innovation. The award ceremony was held on April 24 in Tokyo. The IEEE Corporate Innovation Award is a globally-recognized honor bestowed upon organizations that have developed innovative technologies, products or services that have made a substantial contribution to the advancement of electrical and electronics engineering. Since its inception in 1985, the award has been presented to leading electronics manufacturers and IT companies worldwide, and Kioxia is proud to be the seventh Japanese c
Suzano Reports Record First-Quarter Revenue9.5.2025 03:12:00 EEST | Press release
Suzano, the world’s largest pulp producer, announces its first quarter results for 2025 (1Q25) with record net revenue of R$11.6 billion, up 22% on the same quarter last year (1Q24). The result was driven by the exchange rates, increased pulp sales volumes from the new Ribas do Rio Pardo mill, higher paper volume and prices and the positive contribution from our paperboard mills recently acquired in the U.S. The record revenues occurred despite a series of planned downtimes in the quarter, including production lines of the Três Lagoas Unit, Mucuri Unit, and Aracruz Unit, and the Ribas do Rio Pardo Unit’s first scheduled maintenance downtime. Sales exceeded 3 million tonnes in the quarter, a rise of 12% compared to 1Q24, comprising 2.7 million tonnes of pulp and 390 thousand tonnes of paper, up 10% and 25%, respectively, on the same quarter last year. Adjusted EBITDA totaled R$4.9 billion, a 7% increase over 1Q24. Operating cash generation totaled R$2.6 billion, rising 5% on 1Q24. Net p
GC Aesthetics® Strengthens Board of Directors with Strategic Appointments8.5.2025 18:10:00 EEST | Press release
GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets is pleased to announce the appointment of Mr. Luigi Ferrari as Chairman of the Board (non-executive) and Mr. Patrick Lee as Board Director, reinforcing the company’s strategic direction and long-term growth plans. These appointments follow the renewed phase of partnership initiated in early 2024 with Hayfin Capital Management, a longstanding investor in GCA. This collaboration has brought fresh momentum to the company’s commitment to innovation, safety, and global expansion in aesthetic and reconstructive breast surgery. Luigi Ferrari, a seasoned executive and investor with a proven track record in the healthcare sector, brings deep leadership experience, commercial growth expertise and industry insight. From 2012 to 2022 he was CEO of Lima Corporate, a global medical device company in the joint replacement market, acquired then by Enovis Corp
PPG to invest $380 million to build new U.S. manufacturing facility in Shelby, N.C. for aerospace coatings and sealants8.5.2025 17:30:00 EEST | Press release
PPG (NYSE: PPG) today announced that it will invest $380 million to build a new aerospace coatings and sealants manufacturing facility in Shelby, N.C. Construction on the 62-acre site, which will initially include manufacturing and warehousing units, is set to commence in October 2025 and is expected to be completed in the first half of 2027. The 198,000-square-foot facility will enable the company to continue meeting the growing demands of the aerospace industry. It will employ more than 110 people and produce the full line of PPG’s aerospace coatings and sealants. The additional capacity of this new plant, combined with nearby transport links that improve supply chain and shipping logistics, will help improve service levels for customers. “PPG’s investment in this new manufacturing facility demonstrates the significant demand growth for our world-class technologies and our continued commitment to serving our aerospace customers,” said Tim Knavish, PPG chairman and chief executive off
WHOOP Unveils WHOOP® 5.0 and WHOOP® MG: Powerful New Devices with Breakthrough Health and Longevity Features8.5.2025 17:00:00 EEST | Press release
WHOOP, the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and longevity. Paired with a redesigned WHOOP experience, the devices offer 14-day battery life in a sleeker, seven percent smaller form - and introduce category-defining features, including Healthspan with WHOOP Age, Heart Screener with on-demand ECG, Blood Pressure Insights, and more. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508546933/en/ WHOOP Unveils Next Generation WHOOP® 5.0 and WHOOP® MG These innovations arrive at a pivotal moment when ailing health systems cost more and deliver less. WHOOP is advancing a new solution and a better way - one that empowers people to connect their daily decisions to performance and health outcomes that can be measured and felt. While others track surface-level trends, WHOOP delivers longevity through depth — translati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom